EBC-46 is a novel anti-cancer drug discovered by applying the EcoLogicTM approach to drug discovery from the rainforests of Northern Queensland. This approach has resulted in a drug therapy for solid tumour cancers that is significantly different to other cancer treatments in the market.
For Animals
EBC-46 is proving to be an outstanding anti-cancer drug with potential to revolutionise the way solid tumours are treated in companion animals. To date, EBC-46 has been successful in the treatment of a diverse range of inoperable solid tumours in dogs, cats and horses. In each case tumour destruction occurred within days with rapid healing of the site and no significant side effects. Click here to learn more
For Humans
As the principles behind the formation of cancer between animals and humans are similar it is expected that EBC-46 will have similar effects in humans as in animals. Clinical Phase I trials for EBC-46 in humans is expected to commence in Australia early 2011. Click here to learn more